Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 10 (9), 553-62

Epidemiology and Natural History of HCV Infection

Affiliations
Review

Epidemiology and Natural History of HCV Infection

Behzad Hajarizadeh et al. Nat Rev Gastroenterol Hepatol.

Abstract

Worldwide, an estimated 130-170 million people have HCV infection. HCV prevalence is highest in Egypt at >10% of the general population and China has the most people with HCV (29.8 million). Differences in past HCV incidence and current HCV prevalence, together with the generally protracted nature of HCV disease progression, has led to considerable diversity in the burden of advanced liver disease in different countries. Countries with a high incidence of HCV or peak incidence in the recent past will have further escalations in HCV-related cirrhosis and hepatocellular carcinoma (HCC) over the next two decades. Acute HCV infection is difficult to detect because of the generally asymptomatic nature of the disease and the marginalization of at-risk populations. Around 25% of patients with acute HCV infection undergo spontaneous clearance, with increased rates among those with favourable IL28B genotypes, acute symptoms and in women. The remaining 75% of patients progress to chronic HCV infection and are subsequently at risk of progression to hepatic fibrosis, cirrhosis and HCC. Chronic hepatitis C generally progresses slowly in the initial two decades, but can be accelerated during this time as a result of advancing age and co-factors such as heavy alcohol intake and HIV co-infection.

Similar articles

See all similar articles

Cited by 256 PubMed Central articles

See all "Cited by" articles

References

    1. J Viral Hepat. 2012 Aug;19(8):560-7 - PubMed
    1. Transfusion. 2004 Oct;44(10):1433-40 - PubMed
    1. JAMA. 2007 May 9;297(18):2010-7 - PubMed
    1. Scand J Gastroenterol. 2003 Aug;38(8):864-70 - PubMed
    1. J Infect Dis. 2009 Oct 15;200(8):1216-26 - PubMed

Publication types

Feedback